Tech Company Financing Transactions
Recursion Pharmaceuticals Funding Round
Recursion Pharmaceuticals secured a $239 million Series D investment round on 9/10/2020. Investors included Leaps by Bayer, Advantage Capital Partners and Baillie Gifford.
Leaps by Bayer (Lead Investor) (Juergen Eckhardt)
Baillie Gifford (Marina Record)
Lux Capital (Zavain Dar)
Obvious Ventures (Nan Li)
Salt Lake City, UT 84101
Browse more venture capital transactions:
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs